Segment Information (Tables)	6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]
Schedule of Segment Expenses	Three Months Ended June 30, Six Months Ended June 30, (in thousands) 2026 2025 2026 2025 Research and development Clinical, development and licensing expenses $ 1,732 $ 535 $ 2,944 $ 1,336 Personnel related expenses 1,141 416 1,887 882 Professional fees 854 128 1,387 344 Facility and other overhead expenses 538 167 912 440 Total research and development 4,265 1,246 7,130 3,002 General and administrative Personnel related expenses 2,195 965 4,604 1,949 Professional fees 1,962 397 4,054 2,004 Facility and other overhead expenses 1,046 320 1,827 568 Total general and administrative $ 5,203 $ 1,682 $ 10,485 $ 4,521

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration